Nektaria Alexandri

Statistics

Publications

Citations

401

H-Index

Active since

2009

Affiliations

Merck KGaA, Darmstadt (Germany)(Current)

Royal Holloway University of London

Inserm

Ospedale Policlinico San Martino

Queen Mary University of London

Nektaria Alexandri is an author at Merck KGaA, Darmstadt (Germany) specializing in relapsing-remitting multiple sclerosis treatment, multiple sclerosis, and multiple sclerosis pharmacotherapy.

ORCID

Publications per year

2009–2023

Publications

Identification of an Agrin Mutation that Causes Congenital Myasthenia and Affects Synapse Function

Caroline Huzé, Stéphanie Bauché, Pascale Richard et al. · The American Journal of Human Genetics · 2009 · 168 citations · Full text

Medicine, Genetics, Molecular Genetics +15

Phenotype genotype analysis in 15 patients presenting a congenital myasthenic syndrome due to mutations in DOK7

Asma Ammar, François Petit, Nektaria Alexandri et al. · Journal of Neurology · 2009 · 79 citations

Life Sciences, Genetics, Molecular Genetics +12

Analysis of frequency and severity of relapses in multiple sclerosis patients treated with cladribine tablets or placebo: The CLARITY and CLARITY Extension studies

Nicola De Stefano, Maria Pia Sormani, Gavin Giovannoni et al. · Multiple Sclerosis Journal · 2021 · 31 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +16

Patient Power Revolution in Multiple Sclerosis: Navigating the New Frontier

David Yeandle, Gavin Giovannoni, Nektaria Alexandri et al. · Neurology and Therapy · 2018 · 27 citations · Full text

Nursing, Internal Medicine, Neurology +17

Joint Healthcare Professional and Patient Development of Communication Tools to Improve the Standard of MS Care

Celia Oreja‐Guevara, Stanca Potra, Birgit Bauer et al. · Advances in Therapy · 2019 · 26 citations · Full text

Social Sciences, Communication, Continuity Of Care +15

1–5 of 9